Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. 1995

J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
Department of Medical Chemistry & Biochemistry, University of Innsbruck Medical School, Austria.

Early sensitivities of creatine kinase (CK), CKMB (activity and mass), CKMM and CKMB isoform ratios, myoglobin, cardiac troponin I (cTnI), and cardiac troponin T (cTnT) were compared to find the most sensitive serum marker for acute myocardial infarction (AMI) during the first hours after onset of chest pain. In a prospective study we investigated 37 consecutive patients with AMI who were admitted to the coronary care unit within 4 h after onset of chest pain. Blood samples were drawn every hour for the first 10 h after admission. CKMB mass concentrations, CKMM and CKMB isoform ratios, myoglobin, cTnI, and cTnT increased significantly (P < or = 0.0067) earlier than CK and CKMB activity and were also significantly (P < or = 0.046) and markedly more sensitive on admission. Differences in early sensitivities of myoglobin, CKMB mass, CK isoform ratios, cTnI, and cTnT were small and not significant. Therefore, turnaround time and practicality for emergency determination of methods, specificities of markers, the required specificity in the individual patient, and costs mainly determine the choice among myoglobin, CKMB mass, CK isoforms, cTnI, and cTnT.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009211 Myoglobin A conjugated protein which is the oxygen-transporting pigment of muscle. It is made up of one globin polypeptide chain and one heme group.
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005260 Female Females

Related Publications

J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
December 1996, Scandinavian journal of clinical and laboratory investigation,
J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
December 1999, QJM : monthly journal of the Association of Physicians,
J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
January 1996, Annals of clinical and laboratory science,
J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
November 2002, Clinical biochemistry,
J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
March 1993, Clinical chemistry,
J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
April 1981, British heart journal,
J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
March 1998, Archives of pathology & laboratory medicine,
J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
November 1978, European journal of cardiology,
J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
November 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies,
J Mair, and D Morandell, and N Genser, and P Lechleitner, and F Dienstl, and B Puschendorf
October 1997, American heart journal,
Copied contents to your clipboard!